CHEMBIO DIAGNOSTIC SYSTEMS INC.

ChemBio Diagnostic Systems Inc. specializes in the design, development, and manufacturing of in-vitro diagnostic substances and biological products for veterinary and public health applications. The company leverages its expertise in lateral flow immunoassay platforms, particularly its DPP® (Dual Path Platform) technology, to produce rapid, point-of-care diagnostic kits capable of detecting antibodies against zoonotic and livestock pathogens such as Mycobacterium species. Their technical capabilities span assay formulation, antigen purification, microfluidic device integration, and quality-controlled scale-up of diagnostic reagents, with a demonstrated focus on field-deployable solutions for animal health surveillance. ChemBio’s differentiation lies in its proprietary dual-path assay architecture, which enhances sensitivity and specificity for complex biological matrices, enabling reliable detection in non-human samples including cervid and elephant sera. The company maintains a strong, recurring relationship with the U.S. Department of Agriculture, delivering diagnostic test kits for animal disease monitoring and outbreak response, particularly in wildlife and livestock populations. It also supports the Department of Health and Human Services through research and development initiatives focused on life sciences innovation, including biotechnology-driven diagnostic advancement and protocol optimization for infectious disease detection. ChemBio’s primary industry focus is in NAICS 325413 (in-vitro diagnostic substance manufacturing), where it serves the veterinary diagnostics and One Health sectors by bridging laboratory-grade accuracy with field usability. Secondary work in biological product manufacturing and life sciences R&D reinforces its niche as a developer of specialized diagnostic tools for emerging pathogen threats. Headquartered in Medford, New York, ChemBio operates as a small business with no federal certifications on record. Its geographic presence is centered on its manufacturing and R&D facility, positioning it as a specialized supplier to federal agencies requiring rapid-response diagnostic solutions for animal and human health surveillance.